↓ Skip to main content

Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, August 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
Published in
Arquivos de Neuro-Psiquiatria, August 2016
DOI 10.1590/0004-282x20160091
Pubmed ID
Authors

Caroline Vieira Spessotto, Hanaie Cavalli, Audred Cristina Biondo Eboni, Rafael Berlezi Machado, Analara Munardi Mousquer, Lara Both Palazzo, Alessandro Finkelsztejn, Marcus Vinicius Magno Goncalves, Henry Koiti Sato, Fabio Siquineli, Yara Dadalti Fragoso

Abstract

The treatment of multiple sclerosis (MS) with disease-modifying-drugs (DMDs) is evolving and new drugs are reaching the market. Efficacy and safety aspects of the drugs are crucial, but the patients' satisfaction with the treatment must be taken into consideration. Individual interview with patients with MS regarding their satisfaction and points of view on the treatment with DMDs. One hundred and twenty eight patients attending specialized MS Units in five different cities were interviewed. Over 80% of patients were very satisfied with the drugs in use regarding convenience and perceived benefits. The only aspect scoring lesser values was tolerability. Parameters for improving treatment in MS must include efficacy, safety, and patient satisfaction with the given DMD.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 5%
Unknown 19 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 25%
Student > Master 3 15%
Student > Doctoral Student 2 10%
Student > Bachelor 2 10%
Student > Postgraduate 2 10%
Other 3 15%
Unknown 3 15%
Readers by discipline Count As %
Medicine and Dentistry 7 35%
Nursing and Health Professions 3 15%
Neuroscience 3 15%
Agricultural and Biological Sciences 1 5%
Computer Science 1 5%
Other 1 5%
Unknown 4 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2016.
All research outputs
#22,759,452
of 25,373,627 outputs
Outputs from Arquivos de Neuro-Psiquiatria
#1,141
of 1,369 outputs
Outputs of similar age
#339,043
of 381,036 outputs
Outputs of similar age from Arquivos de Neuro-Psiquiatria
#16
of 22 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,369 research outputs from this source. They receive a mean Attention Score of 4.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,036 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.